Subscribe to Journal
Get full journal access for 1 year
only $102.00 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K, et al. Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children. Leukemia. 2017;31:580–4.
Nielsen SN, Grell K, Nersting J, Abrahamsson J, Lund B, Kanerva J, et al. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Lancet Oncol. 2017;18:515–24.
Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018;60:4–12.
Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann FA, Zhao X, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016;48:367–73.
Zgheib NK, Akika R, Mahfouz R, Aridi CA, Ghanem KM, Saab R, et al. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children’s Cancer Center of Lebanon. Pediatr Blood Cancer. 2017;64:146–50.
Soler AM, Olano N, Mendez Y, Lopes A, Silveira A, Dabezies A, et al. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay. Br J Haematol. 2018;181:252–55.
Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol. 2015;33:1235–42.
Tanaka Y, Kato M, Hasegawa D, Urayama KY, Nakadate H, Kondoh K, et al. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia. Br J Haematol. 2015;171:109–15.
Yang SK, Hong M, Baek J, Choi H, Zhao W, Jung Y, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet. 2014;46:1017–20.
Moriyama T, Nishii R, Lin TN, Kihira K, Toyoda H, Jacob N, et al. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Pharm Genom. 2017;27:236–9.
Moriyama T, Yang YL, Nishii R, Ariffin H, Liu C, Lin TN, et al. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood. 2017;130:1209–12.
Liang DC, Yang CP, Liu HC, Jaing TH, Chen SH, Hung IJ, et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharm J. 2016;16:536–9.
Regan JF, Kamitaki N, Legler T, Cooper S, Klitgord N, Karlin-Neumann G, et al. A rapid molecular approach for chromosomal phasing. PLoS One. 2015;10:e0118270.
Hidaka N, Iwama E, Kubo N, Harada T, Miyawaki K, Tanaka K, et al. Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non-small cell lung cancer. Lung Cancer. 2017;108:75–82.
Chao K, Wang X, Cao Q, Qian J, Wu K, Zhu X, et al. Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in chinese patients with inflammatory bowel disease: a multicenter analysis. Inflamm Bowel Dis. 2017;23:1592–9.
The authors would like to thank Ms. Natsuko Ariizumi, Ms. Shinobu Kobayashi, and Ms. Yoshie Fukumasa for their technical assistance. We also thank Mr. Yukinori Yatsuda (Bio-rad) for his assistance with the ddPCR analysis. The authors thank Mr. James R. Valera of the Department of Education for Clinical Research of the National Center for Child Health and Development for his assistance in proofreading and editing this manuscript. This study was supported in part by the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for Scientific Research (KAKENHI, grant number 17H04234), by a grant from the National Center for Child Health and Development (grant numbers 28-5), by grant 17km0405107h0005, 17ck0106253h0001, and 17ck0106219h0002 from the Japan Agency for Medical Research and development, (AMED), and by foundation for National Institutes of Health (GM118578, GM115279, and P30CA21765) and the V Foundation for Cancer Research (T2015-006). T.M is supported by the Garwood Fellowship at St. Jude Children’s Research Hospital.
MK is the principal investigator and takes primary responsibility for the paper, designed this study, interpreted data, wrote the manuscript, and gave final approval; ST, TO collected data, analyzed data, interpreted data, and wrote the manuscript; TO evaluated patients, collected data, analyzed data, interpreted data, and wrote the manuscript; MU, RS, TM, RN, YY, TU, NK and JJY collected data, analyzed data, interpreted data. KK, MS, YA, KT, SI, KK, JT, EI and DT evaluated patients, and collected data; All authors discussed the results and critically reviewed the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
About this article
Cite this article
Tsujimoto, S., Osumi, T., Uchiyama, M. et al. Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms. Leukemia 32, 2710–2714 (2018). https://doi.org/10.1038/s41375-018-0190-1